Aleksandra Markiewicz
Overview
Explore the profile of Aleksandra Markiewicz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
481
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Topa J, Zaczek A, Markiewicz A
Methods Mol Biol
. 2024 Jan;
2752:43-52.
PMID: 38194026
Circulating tumor cells (CTCs) undergoing epithelial-mesenchymal transition (EMT) may exhibit more aggressive features than epithelial CTCs and are more frequently observed during disease progression. Therefore, detection and characterization of both...
2.
Muchlinska A, Wenta R, Scinska W, Markiewicz A, Suchodolska G, Senkus E, et al.
Cancers (Basel)
. 2023 Aug;
15(16).
PMID: 37627197
Circulating tumor cells (CTCs) and circulating cancer-associated fibroblasts (cCAFs) have been individually considered strong indicators of cancer progression. However, technical limitations have prevented their simultaneous analysis in the context of...
3.
Xiao X, Miao X, Duan S, Liu S, Cao Q, Wu R, et al.
Small Methods
. 2023 Apr;
7(7):e2300096.
PMID: 37086121
The phenotypic changes of circulating tumor cells (CTCs) during the epithelial-mesenchymal transition (EMT) have been a hot topic in tumor biology and cancer therapeutic development. Here, an integrated platform of...
4.
Sakowska J, Arcimowicz L, Jankowiak M, Papak I, Markiewicz A, Dziubek K, et al.
Front Immunol
. 2022 May;
13:793234.
PMID: 35634292
Autoimmune disease results from the immune response against self-antigens, while cancer develops when the immune system does not respond to malignant cells. Thus, for years, autoimmunity and cancer have been...
5.
Nagel A, Popeda M, Muchlinska A, Sadej R, Szade J, Zielinski J, et al.
Cancers (Basel)
. 2022 Apr;
14(8).
PMID: 35454913
Background: Cancer-associated fibroblasts (CAFs) are the most abundant cell type in the tumor microenvironment (TME). Estrogen receptor alpha 36 (ERα36), the alternatively spliced variant of ERα, is described as an...
6.
Topa J, Gresner P, Zaczek A, Markiewicz A
Cell Mol Life Sci
. 2022 Jan;
79(2):81.
PMID: 35048186
Circulating tumor cells (CTCs) mediate dissemination of solid tumors and can be an early sign of disease progression. Moreover, they show a great potential in terms of non-invasive, longitudinal monitoring...
7.
Krupa L, Staron R, Dulko D, Lozinska N, Mackie A, Rigby N, et al.
Molecules
. 2021 Dec;
26(23).
PMID: 34885858
Determination of the cause of a biliary obstruction is often inconclusive from serum analysis alone without further clinical tests. To this end, serum markers as well as the composition of...
8.
Bednarz-Knoll N, Popeda M, Kryczka T, Kozakiewicz B, Pogoda K, Szade J, et al.
Br J Cancer
. 2021 Dec;
126(3):464-471.
PMID: 34857895
Background: Platelets support tumour progression. However, their prognostic significance and relation to circulating tumour cells (CTCs) in operable breast cancer (BrCa) are still scarcely known and, thus, merit further investigation....
9.
Markiewicz A, Topa J, Popeda M, Szade J, Skokowski J, Welnicka-Jaskiewicz M, et al.
Acta Biochim Pol
. 2021 Aug;
68(3):385-392.
PMID: 34432400
Breast cancer (BC) is a heterogeneous disease with different molecular subtypes, which can be defined by oestrogen (ER), progesterone (PR) and human epidermal growth factor (HER2) receptors' status as luminal,...
10.
Popeda M, Markiewicz A, Stokowy T, Szade J, Niemira M, Kretowski A, et al.
Sci Rep
. 2021 Mar;
11(1):5097.
PMID: 33658651
Immune system plays a dual role in cancer by either targeting or supporting neoplastic cells at various stages of disease, including metastasis. Yet, the exact immune-related transcriptome profiles of primary...